We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$371M
AUM Growth
+$79M
Cap. Flow
+$81M
Cap. Flow %
21.84%
Top 10 Hldgs %
6.32%
Holding
972
New
379
Increased
184
Reduced
115
Closed
294

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.87M
2
LEN icon
Lennar Class A
LEN
+$2.79M
3
CAG icon
Conagra Brands
CAG
+$2.49M
4
WEX icon
WEX
WEX
+$2.24M
5
SF
Stifel
SF
+$2.15M

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Healthcare 14.27%
3 Industrials 13.14%
4 Energy 10.34%
5 Financials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
276
ICU Medical
ICUI
$4.48B
$500K 0.13%
+2,248
New +$504K
INSP icon
277
Inspire Medical Systems
INSP
$1.68B
$500K 0.13%
1,949
-151
-7% -$34.5K
QCOM icon
278
Qualcomm
QCOM
$171B
$498K 0.13%
3,262
-1,504
-32% -$252K
SEM
279
DELISTED
Select Medical
SEM
$497K 0.13%
38,419
-18,560
-33% -$245K
JBHT icon
280
JB Hunt Transport Services
JBHT
$25.9B
$496K 0.13%
+2,471
New +$492K
PBA icon
281
Pembina Pipeline
PBA
$28.4B
$492K 0.13%
13,090
+3,041
+30% +$103K
QDEL icon
282
QuidelOrtho
QDEL
$1.02B
$492K 0.13%
+4,374
New +$466K
VEEV icon
283
Veeva Systems
VEEV
$39.2B
$491K 0.13%
2,311
+711
+44% +$154K
ADI icon
284
Analog Devices
ADI
$187B
$490K 0.13%
2,969
-6,731
-69% -$1.09M
BSX icon
285
Boston Scientific
BSX
$74.5B
$489K 0.13%
+11,050
New +$479K
AMD icon
286
Advanced Micro Devices
AMD
$788B
$486K 0.13%
+4,442
New +$530K
BALL icon
287
Ball Corp
BALL
$16.4B
$485K 0.13%
+5,386
New +$490K
SAIA icon
288
Saia
SAIA
$9.73B
$484K 0.13%
1,984
+779
+65% +$216K
VOD icon
289
Vodafone
VOD
$37.2B
$482K 0.13%
+29,027
New +$495K
EBIX
290
DELISTED
Ebix Inc
EBIX
$481K 0.13%
+14,520
New +$454K
PXD
291
DELISTED
Pioneer Natural Resource Co.
PXD
$479K 0.13%
+1,916
New +$433K
TDW icon
292
Tidewater
TDW
$4.56B
$478K 0.13%
+21,968
New +$347K
BHVN
293
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$477K 0.13%
+4,020
New +$501K
AVNS
294
DELISTED
Avanos Medical
AVNS
$476K 0.13%
+14,200
New +$457K
APA icon
295
APA Corp
APA
$14B
$475K 0.13%
11,500
-9,000
-44% -$314K
CYBE
296
DELISTED
Cyberoptics Corp
CYBE
$475K 0.13%
11,704
-796
-6% -$30.6K
GBX icon
297
The Greenbrier Companies
GBX
$1.41B
$474K 0.13%
+9,200
New +$415K
OVV icon
298
Ovintiv
OVV
$17.5B
$473K 0.13%
8,749
-2,501
-22% -$108K
PRKS icon
299
United Parks & Resorts
PRKS
$2.01B
$473K 0.13%
+6,352
New +$417K
WSBF icon
300
Waterstone Financial
WSBF
$378M
$471K 0.13%
24,372
-6,989
-22% -$141K

Similar funds

Campbell & Co Investment Adviser's Q1 2022 Portfolio in Review

As of Q1 2022, Campbell & Co Investment Adviser held 972 positions worth $371M, up 27% from $292M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Campbell & Co Investment Adviser deployed $81M of net new capital in Q1 2022, opening 379 new positions and adding to 184 existing holdings. Its largest new stake was CONTINENTAL RESOURCES INC.: 46,121 shares worth $2.83M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was International Paper, an estimated $1.72M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2022 buy was CONTINENTAL RESOURCES INC.: 46,121 shares worth $2.83M.
  • Campbell & Co Investment Adviser added most to Costco in Q1 2022, an estimated $2.36M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2022 reduction was International Paper, cutting an estimated $1.72M.
  • Campbell & Co Investment Adviser fully exited Medtronic in Q1 2022, selling an estimated $2.87M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.3% of its $371M portfolio in Q1 2022.
  • Campbell & Co Investment Adviser opened 379 new positions and closed 294 in Q1 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 27% quarter-over-quarter to $371M.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2022, filed 9 May 2022.